Company intelligence / Profile preview
SOM Biotech
Montcada i Reixac / Barcelona area*, Catalonia, Spainsombiotech.com ↗
- Ownership
- Private
- Employees
- ~17
- Development stage
- Phase 2
01
Overview
Lead product SOM3355 has successfully completed Phase IIb trials in patients with Huntington's Disease chorea showing robust improvements in chorea symptoms without adverse effects such as somnolence, akathisia, depression or cognitive impact. The FDA granted Orphan Drug Designation for this compound. Other programs have reached Phase IIa proof-of-concept stages with positive outcomes[1][2][6][8].
- Therapeutic areas
- Metabolic DisordersOncologyRare DiseasesNeurologyInfectious Diseases
- Modalities
- Small molecules (e.g., β blocker SOM3355)Drug repurposing using AI technology
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Collaborations include Nippon Chemiphar (Japan) for the SOM3355 program[2], licensing agreements like Corino Therapeutics Inc. for TTR amyloidosis asset[2], plus multiple academic collaborations and industry partnerships[1][2].
Beyond the preview
Go deeper on SOM Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SOM Biotech.